INVO Fertility (IVF) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.56, -5.65% vs the prior close of $0.59.
- Volume 77.23K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IVF slides 5.7% to $0.56, a 52-week low. Closed at $0.56, -5.65% vs the prior close of $0.59. Day range $0.53–$0.60, opened at $0.60.
IVF daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IVF slides 5.7% to $0.56, a 52-week low
- Closed at $0.56, -5.65% vs the prior close of $0.59. Day range $0.53–$0.60, opened at $0.60.
- Volume was 77.23K shares, 0.0x its 50-day average of 2.74M — lighter than usual.
- Price is -41.3% vs its 50-day average ($0.95) and -77.6% vs its 200-day average ($2.48).
- 52-week range $0.51–$84.40; today's close sits at 0% of that range, 99.3% below the 52-week high.
Oct 15, 2026 — IVF ends flat (+0.2%) to $0.59
- Closed at $0.59, +0.17% vs the prior close of $0.59. Day range $0.51–$0.60, opened at $0.58.
- Volume was 174.80K shares, 0.1x its 50-day average of 2.74M — lighter than usual.
- Price is -38.4% vs its 50-day average ($0.96) and -76.4% vs its 200-day average ($2.50).
- 52-week range $0.51–$84.40; today's close sits at 0% of that range, 99.3% below the 52-week high.
Oct 14, 2026 — IVF slides 7.8% to $0.59, a 52-week low, 4 down days in a row
- Closed at $0.59, -7.81% vs the prior close of $0.64. Day range $0.58–$0.67, opened at $0.65.
- Volume was 174.30K shares, 0.1x its 50-day average of 2.73M — lighter than usual.
- Price is -39.1% vs its 50-day average ($0.97) and -76.6% vs its 200-day average ($2.52).
- 52-week range $0.58–$84.40; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — IVF slides 11.8% to $0.64, a 52-week low, 3 down days in a row
- Closed at $0.64, -11.85% vs the prior close of $0.73. Day range $0.63–$0.75, opened at $0.72.
- Volume was 227.20K shares, 0.1x its 50-day average of 2.73M — lighter than usual.
- Price is -34.6% vs its 50-day average ($0.98) and -74.8% vs its 200-day average ($2.54).
- 52-week range $0.63–$84.40; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — IVF ends flat (-0.3%) to $0.73, a 52-week low
- Closed at $0.73, -0.27% vs the prior close of $0.73. Day range $0.71–$0.77, opened at $0.75.
- Volume was 93.30K shares, 0.0x its 50-day average of 2.73M — lighter than usual.
- Price is -26.3% vs its 50-day average ($0.99) and -71.6% vs its 200-day average ($2.55).
- 52-week range $0.71–$84.40; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 9, 2026 — IVF dips 1.6% to $0.73, a 52-week low
- Closed at $0.73, -1.62% vs the prior close of $0.74. Day range $0.71–$0.77, opened at $0.77.
- Volume was 88.40K shares, 0.0x its 50-day average of 2.73M — lighter than usual.
- Price is -26.4% vs its 50-day average ($0.99) and -71.7% vs its 200-day average ($2.57).
- 52-week range $0.71–$84.40; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 8, 2026 — IVF ends flat (+0.3%) to $0.74
- Closed at $0.74, +0.27% vs the prior close of $0.74. Day range $0.74–$0.76, opened at $0.74.
- Volume was 69.70K shares, 0.0x its 50-day average of 2.73M — lighter than usual.
- Price is -25.5% vs its 50-day average ($0.99) and -71.4% vs its 200-day average ($2.59).
- 52-week range $0.71–$84.40; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 7, 2026 — IVF slides 7.2% to $0.74, a 52-week low, 8 down days in a row
- Closed at $0.74, -7.17% vs the prior close of $0.80. Day range $0.71–$0.83, opened at $0.83.
- Volume was 163.80K shares, 0.1x its 50-day average of 2.73M — lighter than usual.
- Price is -26.0% vs its 50-day average ($1.00) and -71.7% vs its 200-day average ($2.61).
- 52-week range $0.71–$84.40; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 8 straight losses.
Oct 6, 2026 — IVF slides 4.1% to $0.80, a 52-week low, 7 down days in a row
- Closed at $0.80, -4.10% vs the prior close of $0.83. Day range $0.79–$0.84, opened at $0.81.
- Volume was 67.00K shares, 0.0x its 50-day average of 2.73M — lighter than usual.
- Price is -20.7% vs its 50-day average ($1.00) and -69.8% vs its 200-day average ($2.63).
- 52-week range $0.76–$84.40; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — IVF slides 3.0% to $0.83, a 52-week low, 6 down days in a row
- Closed at $0.83, -3.04% vs the prior close of $0.86. Day range $0.76–$0.87, opened at $0.87.
- Volume was 145.90K shares, 0.1x its 50-day average of 2.73M — lighter than usual.
- Price is -17.5% vs its 50-day average ($1.01) and -68.8% vs its 200-day average ($2.65).
- 52-week range $0.76–$84.40; today's close sits at 0% of that range, 99.0% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — IVF slides 5.1% to $0.86, a 52-week low, 5 down days in a row
- Closed at $0.86, -5.11% vs the prior close of $0.90. Day range $0.81–$0.90, opened at $0.90.
- Volume was 223.00K shares, 0.1x its 50-day average of 2.73M — lighter than usual.
- Price is -15.2% vs its 50-day average ($1.01) and -68.1% vs its 200-day average ($2.68).
- 52-week range $0.81–$84.40; today's close sits at 0% of that range, 99.0% below the 52-week high.
- That makes 5 straight losses.
IVF latest news & SEC filings
Every SEC filing by or about IVF in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.18M (prior year $1.86M) (+16.7% vs Jun 30, 2025)
- Net income: $888.74K (prior year -$3.62M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.35 (prior year -$364.23) (swung to profit vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 24, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jun 23, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Mar 31, 2026:
- Revenue: $2.02M (prior year $1.64M) (+23.1% vs Mar 31, 2025)
- Net income: -$5.54M (prior year -$17.40M) (loss narrowed vs Mar 31, 2025)
- Diluted EPS: -$3.38 (prior year -$3473.93) (loss narrowed vs Mar 31, 2025)
Things to know before you trade IVF
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: Jun 22, 2026, Jun 2, 2026, Nov 17, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.37% (largest 11.8%). That is a volatile stock.
- Liquidity: about 146.58K shares (≈$81.73K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.56 vs a range of $0.51–$84.40 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Mar 27, 2026, 1:8 on Nov 28, 2025, 1:3 on Jul 21, 2025, 1:12 on Mar 18, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Matthew K Szot sold 4 shares on Dec 3, 2025.
- Latest filings: 8-K Aug 28, 2026; 8-K Aug 17, 2026; 10-Q Aug 14, 2026.
- Share count: 2.51M shares outstanding (Aug 14, 2026), -42.5% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
IVF market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.60 | 0.60 | 0.53 | 0.56 | 77.23K |
| Oct 15, 2026 | 0.58 | 0.60 | 0.51 | 0.59 | 174.80K |
| Oct 14, 2026 | 0.65 | 0.67 | 0.58 | 0.59 | 174.30K |
| Oct 13, 2026 | 0.72 | 0.75 | 0.63 | 0.64 | 227.20K |
| Oct 12, 2026 | 0.75 | 0.77 | 0.71 | 0.73 | 93.30K |
| Oct 9, 2026 | 0.77 | 0.77 | 0.71 | 0.73 | 88.40K |
| Oct 8, 2026 | 0.74 | 0.76 | 0.74 | 0.74 | 69.70K |
| Oct 7, 2026 | 0.83 | 0.83 | 0.71 | 0.74 | 163.80K |
| Oct 6, 2026 | 0.81 | 0.84 | 0.79 | 0.80 | 67.00K |
| Oct 5, 2026 | 0.87 | 0.87 | 0.76 | 0.83 | 145.90K |
| Oct 2, 2026 | 0.90 | 0.90 | 0.81 | 0.86 | 223.00K |
| Oct 1, 2026 | 0.95 | 0.95 | 0.89 | 0.90 | 128.20K |
| Sep 30, 2026 | 0.94 | 0.95 | 0.91 | 0.91 | 72.20K |
| Sep 29, 2026 | 0.95 | 0.95 | 0.91 | 0.91 | 72.10K |
| Sep 28, 2026 | 0.95 | 0.97 | 0.93 | 0.93 | 91.70K |
| Sep 25, 2026 | 0.95 | 1.04 | 0.93 | 0.94 | 504.20K |
| Sep 24, 2026 | 1.00 | 1.02 | 0.94 | 0.94 | 114.60K |
| Sep 23, 2026 | 0.99 | 1.02 | 0.97 | 1.02 | 147.00K |
| Sep 22, 2026 | 0.94 | 1.00 | 0.94 | 1.00 | 135.70K |
| Sep 21, 2026 | 0.96 | 0.99 | 0.93 | 0.96 | 161.30K |
About INVO Fertility
INVO Fertility (IVF) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SARASOTA, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1417926.
IVF board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steve Shum | Chief Executive Officer | Oct 3, 2025 |
| Matthew K Szot | Director | Dec 5, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Terah Renee Krigsvold | Chief Financial Officer | Jan 13, 2026 |
| Steve Shum | Chief Executive Officer | Oct 3, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 3, 2025 | Matthew K Szot | Sale | 4 | $1.52 |
| Dec 3, 2025 | Matthew K Szot | Sale | 4 | $1.52 |
| Dec 3, 2025 | Matthew K Szot | Sale | 4 | $1.52 |
| Dec 3, 2025 | Matthew K Szot | Sale | 4 | $1.52 |
IVF financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-23.32M | -214.64 | $-7.01M |
| Dec 31, 2024 | $6.56M | $-9.26M | -3,782.65 | $-2.97M |
| Dec 31, 2023 | $3.02M | $-8.03M | -67.37 | $-4.76M |
| Dec 31, 2022 | $822.20K | $-10.89M | -17.97 | $-6.60M |
| Dec 31, 2021 | $4.16M | $-6.65M | -0.63 | $-6.03M |
Latest balance sheet: total assets $25.83M, total liabilities $9.34M, cash $1.96M (as of Jun 30, 2026).
IVF earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $1.53 |
| Jun 22, 2026 | 8-K Item 2.02 (results) | $1.39 |
| Jun 2, 2026 | 8-K Item 2.02 (results) | $1.52 |
| Nov 17, 2025 | 8-K Item 2.02 (results) | $18.32 |
| Aug 15, 2025 | 8-K Item 2.02 (results) | $62.80 |
| May 21, 2025 | 8-K Item 2.02 (results) | $234.60 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $286.80 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Apr 16, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IVF
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.